{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:09:48Z","timestamp":1776186588095,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10728,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1982,9,10]]},"abstract":"<jats:p>The development of an intravenous form of nitroglycerin has further enhanced the role of nitrates in the therapy of cardiovascular disorders. This new preparation permits prompt initiation of therapy and rapid attainment of high systemic levels; because of its short half\u2010life, rapid dose titration is both feasible and safe. The antianginal effects of intravenous nitroglycerin are useful in the treatment of coronary vasospasm and unstable angina pectoris. Its hemodynamic effects are of benefit in the therapy of congestive heart failure and in the control of peri\u2010operative hypertension. Recent data suggest that, with appropriate monitoring, intravenous nitroglycerin can be safely administered to patients with evolving myocardial infarction to reduce the extent of myocardial damage.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1982.tb03197.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T13:38:40Z","timestamp":1450273120000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Use of Intravenous Nitroglycerin in Cardiovascular Disease"],"prefix":"10.1002","volume":"2","author":[{"given":"Allan S.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"80","article-title":"Nitroglycerin in angina pectoris","volume":"1","author":"Murrell W.","year":"1979","journal-title":"Lancet."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.55.2.381"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.50.2.348"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600630620"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(81)90329-5"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.5.694"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960030607"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(59)90003-8"},{"key":"e_1_2_1_10_2","first-page":"295","volume-title":"Current cardiology: coronary artery spasm","author":"Pepine CJ","year":"1980"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331976301400105"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90408-9"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.1.33"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.2.411"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(77)90060-1"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90080-6"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197812072992303"},{"key":"e_1_2_1_18_2","first-page":"416","article-title":"Intravenous nitroglycerin in refractory unstable angina","volume":"41","author":"Dauwe F","year":"1979","journal-title":"Am J Cardiol."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.79.1.69"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.77.3.375"},{"issue":"3","key":"e_1_2_1_21_2","first-page":"194","article-title":"Intermittent and continuous nitroglycerin infusions for control of myocardial ischemia (abstract)","volume":"56","author":"Leinbach RC","year":"1977","journal-title":"Circulation."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197708042970506"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.2.322"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.6.1118"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.1.160"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108040"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1152\/jappl.1970.29.1.17","article-title":"Effects of nitroglycerin on flow after partial obstruction of the coronary artery","volume":"29","author":"Malindzak GS","year":"1970","journal-title":"J Appl Physiol."},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106645"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.54.5.766"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198105213042101"},{"issue":"1","key":"e_1_2_1_31_2","first-page":"26","article-title":"Comparative hemodynamic responses to chlorpromazine, nitroprusside, nitroglycerin, and trimeth\u2010aphan immediately after open\u2010heart operations","volume":"51","author":"Stinson ED","year":"1975","journal-title":"Circulation."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03007436"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-5223(19)40974-4","article-title":"Vasodilator therapy during coronary artery surgery","volume":"77","author":"Kaplan JA","year":"1979","journal-title":"J Thorac Cardiovasc Surg."},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197607000-00004"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/51.11.1063"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1980.tb01536.x"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197807000-00006"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1978.48.5.0704"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.56.3.366"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-193210000-00005"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.38.6.612"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197511132932002"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.6.1227"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.63.1.17"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.63.3.615"},{"key":"e_1_2_1_46_2","first-page":"737","article-title":"Extent of inferior myocardial infarction with intravenous nitroglycerin: a randomized prospective study (abstract)","volume":"64","author":"Jaffe AS","year":"1981","journal-title":"Circulation."},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600700923"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.54.4.624"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(78)90170-9"},{"key":"e_1_2_1_50_2","first-page":"22","article-title":"Incompatibilities with nitroglycerin solutions","volume":"7","author":"Mehl B.","year":"1981","journal-title":"Primary Cardiol."},{"key":"e_1_2_1_51_2","first-page":"209","article-title":"Nitroglycerin infusion: Factors influencing the concentration of nitroglycerin available to the patient","volume":"5","author":"Christiansen H","year":"1980","journal-title":"J Clin Hosp Pharm."},{"key":"e_1_2_1_52_2","first-page":"201","article-title":"Compatibility with intravenous fluid filters, containers, and administration sets","volume":"37","author":"Baaske DM","year":"1980","journal-title":"Am J Hosp Pharm."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03197.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03197.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1982.tb03197.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:29Z","timestamp":1761042269000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1982.tb03197.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,9,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1982.tb03197.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1982.tb03197.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,9,10]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}